RK
Ravi Kharbas
About Ravi Kharbas
Data last updated:
Ravi Kharbas has 7 years in corporate governance. Holds Designated Partner and Director roles. Currently with 2 companies, including Pink Pearl Pharma Llp and Cmayds Technologies Private Limited. Engaged in General Business, Technology. Contributes to corporate operations. The largest current company by reported revenue is Cmayds Technologies Private Limited at ₹0.20 Cr (FY 2020).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 12 Dec 2018 | 2018 | ₹0.20 Cr (FY 2020) | Active | |
| Designated Partner | 26 Jun 2019 | 2019 | – | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Ravi Kharbas
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ravi Kharbas
Ravi Kharbas has 7 years in corporate governance. Holds Designated Partner and Director roles. Currently with 2 companies, including Pink Pearl Pharma Llp and Cmayds Technologies Private Limited. Engaged in General Business, Technology. Contributes to corporate operations. The largest current company by reported revenue is Cmayds Technologies Private Limited at ₹0.20 Cr (FY 2020).
Ravi Kharbas is associated with 2 companies as Designated Partner and Director, including Cmayds Technologies Private Limited (₹0.20 Cr), Pink Pearl Pharma Llp.
Ravi Kharbas has expertise in General Business, Technology.
Ravi Kharbas has 7 years in corporate governance.
By reported revenue, the largest current company of Ravi Kharbas is Cmayds Technologies Private Limited, with revenue of ₹0.20 Cr (FY 2020).
Ravi Kharbas currently holds positions at 2 companies: Cmayds Technologies Private Limited (₹0.20 Cr), Pink Pearl Pharma Llp.